Polymorphs of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine are provided herein. Processes for preparing the polymorphs and pharmaceutical composition comprising the polymorphs are also disclosed.
本文提供了N4-(4-(
[1,2,4]三唑并[1,5-a]吡啶-7-氧基)-3-甲基苯基)-N6-(4,4-二甲基-4,5-二氢
噁唑-2-基)
喹唑啉-4,6-二胺的多晶形态。本文还公开了制备多晶形态的方法和包含多晶形态的制药组合物。